Using an elegant approach in which the A2AR was specifically deleted in myeloid cells (using a Lys-Cre system) Cekic et al. were able to show that the A2AR limited anti-tumor immune responses in part through modulation of myeloid cells and subsequent enhancement of anti-tumor T cell responses [190]. Here, ADORA2A is linked to neoplasm.